| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Berman-Gund Laboratory for the Study of Retinal Degenerations and the 2 Ocular Molecular Genetics Institute, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.
PURPOSE. To measure the rate of progression of retinal degeneration in patients with retinitis pigmentosa due to dominant rhodopsin mutations and to determine whether the rate of progression correlates with the location of the altered amino acid in the rhodopsin molecule.
METHODS. Change in ocular function was observed for an average of 8.7 years in 140 patients. After censoring data to eliminate "ceiling" and "floor" effects, longitudinal rates of change were compared, after weighting by follow-up time and number of visits, with rates inferred from cross-sectional analyses of the data from baseline visits. Mean rates of change were compared among groups of patients with mutations affecting the globule, plug, or C-terminal region of the protein after adjusting for age, gender, and baseline function.
RESULTS. Mean annual exponential rates of decline were 1.8% for visual acuity, 2.6% for visual field area, and 8.7% for ERG amplitude. The rates of visual acuity and ERG amplitude decline were significantly faster, and the rate of visual field area decline was significantly slower, than those inferred from baseline visits. Rates of acuity loss did not vary significantly with the region affected by the mutation. In contrast, the mean annual rate of field loss in the C terminus group (7.4%) was significantly faster than that in the globule (1.7%) or plug (1.1%) group. The mean annual rate of ERG decline was also significantly faster in the C terminus group (13.5%) than in the globule (8.5%) or plug (3.7%) groups and significantly faster in the globule group than in the plug group.
CONCLUSIONS. Rates of decline in visual function for groups of patients with rhodopsin mutations cannot be accurately inferred from cross-sectional analyses of baseline visits. Average rates of decline of visual field area and ERG amplitude are fastest in patients with mutations affecting the C-terminal region.
This article has been cited by other articles:
|
|
 |
|
  T. S. Aleman, A. V. Cideciyan, A. Sumaroka, E. A. M. Windsor, W. Herrera, D. A. White, S. Kaushal, A. Naidu, A. J. Roman, S. B. Schwartz, et al. Retinal Laminar Architecture in Human Retinitis Pigmentosa Caused by Rhodopsin Gene Mutations Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1580 - 1590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gu, W. A. Beltran, Z. Li, G. M. Acland, and G. D. Aguirre Clinical Light Exposure, Photoreceptor Degeneration, and AP-1 Activation: A Cell Death or Cell Survival Signal in the Rhodopsin Mutant Retina? Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 4907 - 4918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Sandberg, B. Rosner, C. Weigel-DiFranco, T. P. Dryja, and E. L. Berson Disease Course of Patients with X-linked Retinitis Pigmentosa due to RPGR Gene Mutations Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1298 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Tam, G. Xie, D. D. Oprian, and O. L. Moritz Mislocalized Rhodopsin Does Not Require Activation to Cause Retinal Degeneration and Neurite Outgrowth in Xenopus laevis J. Neurosci., January 4, 2006; 26(1): 203 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wada, M. A. Sandberg, T. L. McGee, M. A. Stillberger, E. L. Berson, and T. P. Dryja Screen of the IMPDH1 Gene among Patients with Dominant Retinitis Pigmentosa and Clinical Features Associated with the Most Common Mutation, Asp226Asn Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1735 - 1741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Deretic, A. H. Williams, N. Ransom, V. Morel, P. A. Hargrave, and A. Arendt Rhodopsin C terminus, the site of mutations causing retinal disease, regulates trafficking by binding to ADP-ribosylation factor 4 (ARF4) PNAS, March 1, 2005; 102(9): 3301 - 3306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K T Oh, D M Oh, R G Weleber, E M Stone, A Parikh, J White, K A DeBoer-Shields, L Streb, and C Vallar Genotype-phenotype correlation in a family with Arg135Leu rhodopsin retinitis pigmentosa Br. J. Ophthalmol., December 1, 2004; 88(12): 1533 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bosch, E. Ramon, L. J. Del Valle, and P. Garriga Structural and Functional Role of Helices I and II in Rhodopsin: A NOVEL INTERPLAY EVIDENCED BY MUTATIONS AT GLY-51 AND GLY-89 IN THE TRANSMEMBRANE DOMAIN J. Biol. Chem., May 23, 2003; 278(22): 20203 - 20209. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
